WYETH WYE (NYSE)

(TRENTON, N.J.)Profits posted Wednesday by Pfizer Inc. and Wyeth show a common theme among pharmaceutical companies--nearly all the growth they're seeing these days is overseas, driven by emergin...READ MORE

(MADISON, N.J.)Wyeth said Wednesday its second-quarter profit fell 6.3 percent on charges for severance and other costs related to ongoing job cuts, but the drug developer still topped Wall Stree...READ MORE

(NEW YORK)Shares of drug developer Wyeth rose in premarket trading Wednesday after the company posted strong second-quarter results, and forecast a full-year profit that is above analyst exp...READ MORE

(MADISON, N.J.)Wyeth, the world's No. 12 drug company by revenue, reports earnings for the second quarter on Wednesday morning. The following is a summary of key developments and analyst opinion ...READ MORE

(NEW YORK)Shares of big drug makers fell Friday after a Citi Investment Research gave "Hold" ratings to most of the sector, assigning a top rating only to Merck & Co. and saying Pfizer may n...READ MORE

(NEW YORK)Drug developer Wyeth said Wednesday a U.S. court approved a settlement with generic competitor Impax Laboratories, ending a patent lawsuit over an extended-release version of Wyeth...READ MORE

(NEW YORK)Consumer goods company Procter & Gamble Co. agreed to sell its ThermaCare heat wrap business to a unit of drug maker Wyeth on Tuesday. The ThermaCare line includes six kinds of hea...READ MORE